Whittier Trust Co. Has $166,000 Position in Hill-Rom Holdings Inc. (HRC)
Whittier Trust Co. held its stake in Hill-Rom Holdings Inc. (NYSE:HRC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,300 shares of the medical technology company’s stock at the end of the second quarter. Whittier Trust Co.’s holdings in Hill-Rom Holdings were worth $166,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in HRC. Bank of Montreal Can bought a new position in Hill-Rom Holdings during the second quarter worth approximately $15,483,000. Mitra Capital LLC bought a new position in Hill-Rom Holdings during the first quarter worth approximately $4,490,000. Parametrica Management Ltd bought a new position in Hill-Rom Holdings during the second quarter worth approximately $321,000. UBS Group AG increased its position in Hill-Rom Holdings by 17.2% in the first quarter. UBS Group AG now owns 91,814 shares of the medical technology company’s stock worth $4,618,000 after buying an additional 13,443 shares during the period. Finally, BlackRock Group LTD increased its position in Hill-Rom Holdings by 46.4% in the first quarter. BlackRock Group LTD now owns 62,884 shares of the medical technology company’s stock worth $3,163,000 after buying an additional 19,939 shares during the period. 83.11% of the stock is owned by institutional investors and hedge funds.
Hill-Rom Holdings Inc. (NYSE:HRC) traded down 0.70% on Friday, hitting $59.58. 263,331 shares of the stock were exchanged. Hill-Rom Holdings Inc. has a 1-year low of $42.99 and a 1-year high of $63.12. The stock has a market cap of $3.90 billion, a PE ratio of 61.36 and a beta of 1.14. The company’s 50 day moving average is $60.19 and its 200 day moving average is $53.85.
Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.05. The firm earned $655.40 million during the quarter, compared to analysts’ expectations of $647.75 million. Hill-Rom Holdings had a net margin of 2.47% and a return on equity of 16.62%. The company’s revenue was up 38.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.62 earnings per share. On average, equities research analysts expect that Hill-Rom Holdings Inc. will post $3.33 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 30th. Shareholders of record on Friday, September 16th were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend was Wednesday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 73.91%.
HRC has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Wednesday, September 21st. KeyCorp reiterated a “buy” rating and set a $59.00 price objective on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $62.20.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.